Web Results

jamanetwork.com/collections/5868/prostate-cancer

Explore the latest in prostate cancer, including recent screening ... Assessment of Prostate Cancer Treatment Among Black and White Patients During the ...

www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm596768.htm?utm_content=buffer2d68a&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

Feb 14, 2018 ... The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not ...

www.pennmedicine.org/cancer/types-of-cancer/prostate-cancer

Cancer specialists diagnose and develop treatment plans for prostate cancer using the latest tests and procedures at the Abramson Cancer Center.

clinicaltrials.ucsf.edu/prostate-cancer

Jul 15, 2021 ... Hormone therapy using apalutamide may fight prostate cancer by blocking the ... Whenever possible, a new bone lesion or new/progressing soft ...

moffitt.org/cancers/prostate-cancer/faqs/what-is-the-most-effective-treatment-for-prostate-cancer

Prostate cancer treatment is among our specialties at Moffitt Cancer Center. ... which allows patients to experience the latest breakthroughs in treatment ...

news.tulane.edu/pr/molecularly-targeted-radiation-therapy-extends-survival-patients-advanced-prostate-cancer

Jun 3, 2021 ... A new cancer treatment that uses engineered radioactive molecules to target prostate cancer cells and inhibit tumor growth extended survival ...

www.canceraustralia.gov.au/affected-cancer/cancer-types/prostate-cancer/treatment-options

Sipuleucel-T is a drug that uses your own white blood cells to destroy prostate cancer cells. It is used to treat advanced cancer or cancer that has spread.

www.youtube.com/watch?v=-43fmiJ1oKM

There is a new treatment for men with advanced prostate cancer that seems to buy those men more time.When prostate cancer is found in men ...

emedicine.medscape.com/article/1967731-treatment

Feb 2, 2021 ... In recent years, however, several new therapies have been approved that prolong survival in men whose disease progresses on ADT. In patients ...

jhoonline.biomedcentral.com/articles/10.1186/s13045-020-00978-z

Oct 28, 2020 ... Metastatic castration-resistant prostate cancer (mCRPC) remains a terminal ... While progress is ongoing for many new targeted treatments in ...

www.bu.edu/shipley/prostate-cancer-treatment/advances-in-treatment

The FDA has recently approved several new hormone agents that are stronger and safer than older agents and have better outcomes: enzalutamide (Xtandi®), a ...